Frank Seebach
Impact in
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Hepatology top 10%
- Liver Disease and Transplantation
Papers in
- Oncology 25
- Cancer Immunotherapy and Biomarkers 13
- CAR-T cell therapy research 9
-
- Lung Cancer Treatments and Mutations 7
- Prostate Cancer Treatment and Research 5
- Co-authors
- Michael Kashgarian (4 shared papers)M. Zimpfer (3 shared papers)C. Gonano (3 shared papers)Michael Felfernig (3 shared papers)Alex M. Blaicher (3 shared papers)Christian Sitzwohl (3 shared papers)Norman J. Siegel (2 shared papers)Scott K. Van Why (2 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Annals of Oncology (5 papers)Journal of Thoracic Oncology (2 papers)Anesthesia & Analgesia (2 papers)Cancer (2 papers)
- Partner nations
- United StatesTürkiyeGermany
In The Last Decade
Frank Seebach
37 papers receiving 434 citations
Peers
Comparison fields: 5 of 58
- Critical Care and Intensive Care Medicine 58
- Hepatology 52
- Oncology 166
- Hematology 56
- Nephrology 21
Countries citing papers authored by Frank Seebach
This map shows the geographic impact of Frank Seebach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Seebach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Seebach more than expected).
Fields of papers citing papers by Frank Seebach
This network shows the impact of papers produced by Frank Seebach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Seebach. The network helps show where Frank Seebach may publish in the future.
Co-authors
The 25 scholars most cited alongside Frank Seebach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 66 | |
| 2 | 2020 | 51 | |
| 3 | 2002 | 51 | |
| 4 | 2023 | 50 | |
| 5 | 1998 | 43 | |
| 6 | 1999 | 33 | |
| 7 | 2022 | 21 | |
| 8 | 2023 | 17 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2020 | 7 | |
| 13 | 2022 | 7 | |
| 14 | 1998 | 7 | |
| 15 | 2024 | 6 | |
| 16 | 2001 | 6 | |
| 17 | 2024 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 2024 | 4 |
About Frank Seebach
Frank Seebach is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Immunology and Epidemiology, having authored 41 papers that have together received 441 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (9 papers), Lung Cancer Treatments and Mutations (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Prostate Cancer Treatment and Research (5 papers), Immunotherapy and Immune Responses (5 papers) and Nonmelanoma Skin Cancer Studies (5 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (58 citations), Hepatology (52 citations), Oncology (166 citations), Hematology (56 citations) and Nephrology (21 citations). Frank Seebach has collaborated with scholars based in United States, Türkiye and Germany. Frequent co-authors include Michael Kashgarian, M. Zimpfer, C. Gonano, Michael Felfernig, Alex M. Blaicher, Christian Sitzwohl, Norman J. Siegel, Scott K. Van Why, Stephan C. Kettner and Israel Lowy. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Anesthesia & Analgesia and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.